ViralClear Opens Enrollment with First Patient Dosing in Phase II Human Trial of Anti-Viral MMPD Oral Solution for Treatment of COVID-19

Press/Media: Expert Comment

PeriodJun 17 2020

Media coverage

14

Media coverage

Keywords

  • COVID-19